A total of 44,078 pregnant women who had been admitted to health facilities for spontaneous or induced vaginal delivery were screened for eligibility. After all exclusions, including evidence of coronavirus disease 2019 (Covid-19) and other infections, 14,590 women were assigned to receive azithromycin and 14,688 to receive placebo. ITT denotes intention to treat.